Focus
Longevity Investors: Angels and VC Firms
The RaiseHunt database lists 124 Longevity investors: 24 angel investors and 100 people at 48 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, New York and Boston.
Strongest in San Francisco, New York and Boston
- 124
- Longevity investors
- 24
- Angel investors
- 100
- People at VC/PE firms
- 48
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
124 Longevity investors
Showing 1-20
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Peter H. Diamandis Co-Founder at BOLD Capital Partners | Santa Monica, United States | AngelOperator angel | FinTechHealthcare | View profile | |
Marc P. Bernegger Founding Partner at Maximon - The Longevity Company Builder | Zürich, Switzerland | AngelOperator angel | ConsumerFinTech | View profile | |
Tobias Reichmuth Hon. Chairman & Founder at SUSI Partners | Zug, Switzerland | AngelOperator angel | Healthcare | View profile | |
Bill Cherman angel investor and operator angel | San Francisco, United States | AngelOperator angel | ConsumerHealthcare | View profile | |
Christopher Tracy Investor at Thynk Ventures | Orlando, United States | Venture capital | AIClimate | View profile | |
Facundo Garretón Founder & C.E.O at Terraflos | Uruguay | AngelOperator angel | ConsumerFood | View profile | |
Marianne Mertens Investment Committee Member at Alzheimer's Drug Discovery Foundation | Munich, Germany | Venture capital | Healthcare | View profile | |
Simona Testoni impact at A|impact | Milan, Italy | Venture capital | Healthcare | View profile | |
Imran Shaikh Affiliated at Juvenescence | Muscat, Oman | Corporate VC | AIHealthcare | View profile | |
Noramay Cadena Cofounder & Managing Partner at MiLA Capital | Los Angeles, United States | AcceleratorFamily Office | AIClimate | View profile | |
Nichol Bradford Co-Founder at NIREMIA Collective | San Francisco, United States | Corporate VCVenture capital | AIEducation | View profile | |
Olga Laouchez EIR at Greentown Labs | New York, United States | AcceleratorVenture capital | AIClimate | View profile | |
Stefano Vitella Ciia impact at A|impact | Italy | Venture capital | Healthcare | View profile | |
Shefali Sanghi Strategy Consultant at Thynk Ventures | New York, United States | Venture capital | AIClimate | View profile | |
Jodi Morris Investor & Advisor at Renew Capital | Santa Fe, United States | Venture capital | AIClimate | View profile | |
Katrina Sather Investor at E8 Angels | Seattle, United States | Syndicate / Angel groupVenture capital | AIClimate | View profile | |
Jana Mike Mentee at Threshold Impact | San Francisco, United States | AcceleratorSyndicate / Angel group | AICommerce | View profile | |
Christophe Spoerry angel investor and operator angel | Cannes, France | AngelOperator angel | FinTechSaaS | View profile | |
Jennifer Ehlen-Albrecht Managing Partner at JDE Capital | St Louis, United States | Venture capital | AICommerce | View profile | |
Tim Juergens SeedLink SL at Seedlink Ventures | Spain | Venture capital | Healthcare | View profile |
84 of 124 Longevity investors, A to Z
Grouped by first letter. Name and profile link only, the detailed rows are in the table above.ShowHide
A11
- Adam Stuart
- Aki Ohashi
- Alexander Pickett
- Alexandra Sharon Bause
- Alix Marduel
- Altar Munis
- Amalia Formoso
- Amritha Appaswami
- Anastasia Bottos
- Artem A. Trotsyuk
- Aya Suzuki
B5
- Ben Hassler
- Ben Tomaszewski
- Beth Cohen
- Blerina Sanocki
- Bodil Arlander
C1
- Christina Jenkins
D5
- Dan Herr
- Daniel Ek
- David Berry
- David Berry
- Dmitry Kaminskiy
E4
- Elizabeth H.
- Elizabeth Torres
- Emilian Popa
- Emily Rhen
F2
- Fatimah Bello
- Franco Cortese
G2
- Gabriel Kienberger
- Guenther Dobrauz-Saldapenna
H3
- Hannah Bronfman
- Hannah Konitshek
- Hayk Danielyan
J10
- Jacob Peters
- James Fickel
- Jan Adams
- Jan Adams
- Janet Gurwitch
- Jean-Evrard Dominicé
- Joanna Zhu
- John Reynertson
- Judy Curry
- Julio de Unamuno IV
K2
- Karly Kaplan
- Katerina Stroponiati
L5
- Lawrence Maina
- Liam Cole
- Lisa Dyson
- Lyne Landry
- Lynn Marsh
M3
- Madison Flood
- Matthew Miller
- Milena Bursztyn
O3
- Ole Mensching
- Oleg Teterin
- Omiros D. Sarikas
P5
- Paolo Binetti
- Patrick Nicoll
- Petr Novotný
- Petr Sramek
- Pradeep Killamsetty
R2
- Rakesh Somani
- Robin Farmanfarmaian
S10
- Saima Hasan
- Salil S. Jha
- Sally Cole
- Sean Mahsoul
- Sebastian Döring
- Sébastien Lacroix
- Sergei Glukhov
- Sergej Fedorovič
- Sergey Young
- Sourav Sinha
T3
- Ted Moskovitz
- Tim Davis
- Tony Robbins
U1
- Ulrich K.
V5
- Valentina Vitols Bello
- Varun Verma
- Veeral Mehta
- Veronica Gominho
- Vlad Cernouţan
W1
- Whit Hill
Y1
- Yvette Sadler Butler
Frequently asked questions
How many Longevity investors are on RaiseHunt?
RaiseHunt currently lists 124 Longevity investors.
Are Longevity investors angels or funds?
Both. 24 are angel investors putting in their own money, and 100 are people making investment decisions at 48 firms.
Where are most Longevity investors based?
The largest concentrations are in San Francisco, New York and Boston.
What stage do Longevity investors invest at?
Most list Seed and Series A among the rounds they take part in.
How do I contact Longevity investors?
Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.
Is the list of Longevity investors free to browse?
Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.
Do Longevity investors only back Longevity companies?
No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.
What do investors look at first?
The team and the problem, in that order, before the product. Early on there is rarely enough traction to argue from numbers alone, so the question they are answering is whether these particular people are likely to work this problem out.
Should I raise from one investor or several?
Several, in almost every case. A single backer concentrates the risk of the round collapsing if that one conversation goes cold, and a group brings more introductions later. Rounds are usually assembled from a lead plus others who follow.
How do I follow up without being annoying?
Follow up with new information rather than a reminder. A short note saying what changed since you last wrote gives the reader a reason to reply, where "just checking in" gives them none. Two or three of those, spaced out, is normal and expected.
What if no Longevity investor replies?
Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.
What is the difference between an angel investor and a VC fund?
An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal
